Medivir to present at the ABGSC Life Science Summit
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will present at the virtual meeting ABGSC Life Science Summit, today, May 25. The company will be represented by Magnus Christensen, interim CEO, and Fredrik Öberg, Chief Scientific Officer. The presentation will be available after the seminar on Medivirs website; www.medivir.com. For additional information, please contactMagnus Christensen, interim CEO and CFOTelephone: +46 8 5468 3100E-mail: magnus.christensen@medivir.com Medivir in briefMedivir develops innovative drugs with a focus on